Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 88,123 | 7,296 | 10,596 | 19,335 | 9,766 |
| Operating Income | -88,123 | -7,296 | -10,596 | -19,335 | -9,766 |
| Interest Expense | 1,468 | 0 | 0 | 0 | 9 |
| Other Income | 5,867 | 1,957 | 670 | 13 | 28 |
| Pre-tax Income | -83,724 | -5,339 | -9,926 | -19,322 | -9,747 |
| Income Tax | N/A | N/A | N/A | N/A | -9 |
| Net Income Continuous | -83,724 | -5,339 | -9,926 | -19,322 | -9,738 |
| Net Income | $-83,724 | $-5,339 | $-9,926 | $-19,322 | $-9,738 |
| EPS Basic Total Ops | -3.87 | -4.44 | -8.28 | -16.69 | -24.85 |
| EPS Basic Continuous Ops | -4.99 | -4.45 | -8.27 | -16.68 | -24.82 |
| EPS Diluted Total Ops | -3.87 | -4.44 | -8.28 | -16.69 | -24.85 |
| EPS Diluted Continuous Ops | -4.99 | -4.45 | -8.27 | -16.68 | -24.82 |
| EPS Diluted Before Non-Recurring Items | -5.79 | -4.44 | -8.28 | -16.69 | -24.85 |
| EBITDA(a) | $-90,341 | $-7,185 | $-10,482 | $-19,244 | $-9,673 |